Table 2.
Maternal and perinatal outcome of the total study population and between native and nonnative Dutch women with pregestational type 2 diabetes.
| Complications | DM2 (n = 272) | MV | % | Native Dutch (n = 80) | MV | % | Nonnative Dutch (n = 192) | MV | % | P value |
|---|---|---|---|---|---|---|---|---|---|---|
| Maternal | ||||||||||
| Preeclampsia/HELLP | 29 | 17 | 11.4 | 11 | 1 | 13.9 | 18 | 6 | 9.7 | 0.162 |
| Prematurity | 52 | 0 | 19.1 | 16 | 0 | 20 | 36 | 0 | 18.8 | 0.811 |
| Caesarean section | 114 | 1 | 42.1 | 44 | 0 | 55 | 70 | 1 | 36.6 | 0.005 |
| Primary | 65 | 1 | 24.1 | 29 | 0 | 36.3 | 36 | 1 | 18.8 | 0.007 |
| Secondary | 49 | 1 | 18.1 | 15 | 0 | 18.8 | 34 | 1 | 17.8 | 0.797 |
| Perinatal | ||||||||||
| Perinatal mortality | 13 | 0 | 4.8 | 3 | 0 | 3.8 | 10 | 0 | 5.2 | 0.607 |
| Congenital malformations | 17 | 3 | 6.3 | 7 | 1 | 8.8 | 10 | 2 | 5.3 | 0.269 |
| Macrosomia | 85 | 6 | 32.0 | 24 | 2 | 30.8 | 61 | 4 | 32.4 | 0.789 |
MV: missing values due to inappropriate data of follow-up.